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Abstract
Background: Factors associated with survival prognosis among patients who undergo endovascular aortic repair
(EVAR) for ruptured abdominal aortic aneurysms (rAAA) have not been sufficiently investigated. In the present
study, we examined correlations between perioperative coagulopathy and 24-h and 30-day postoperative survival.
Relationships between coagulopathy and the content of blood transfusions, volumes of crystalloid infusion and
survival.
Methods: This was a retrospective study of the medical records of all patients who underwent EVAR for rAAA at
Chiba-Nishi General Hospital during the period from October 2013 to December 2015. Major coagulopathy was
defined using the international normalized ratio or activated partial thromboplastin time (APTT) ratio of at least
1.5, or platelet count less than 50 × 10/l. We quantified the amounts of blood transfusions and crystalloid infusions
administered from arrival to the hospital to admission to ICU following operations.
Results: Coagulopathy among patients with rAAA was found to progress even after they had presented at the
hospital. No statistically significant correlation between preoperative coagulopathy and mortality was found,
although a significantly greater degree of postoperative coagulopathy was seen among patients who died both
within 24-h and 30 days postoperatively. Among patients with postoperative coagulopathy, lesser quantities of
fresh frozen plasma (FFP) compared with red cell concentrate (RCC) were used during the period from hospital
arrival to postoperative ICU entry. In both groups of patients who did not survive after 24-h and 30 days, FFP was
used less than RCC. Large transfusions of crystalloids administered during the periods from hospital arrival to
surgery and from hospital arrival to the end of surgery were associated with postoperative incidence of major
coagulopathy, death within 24-h, and death within 30 days.
Conclusion: Coagulopathy progressed during care in the emergency outpatient clinic and operations. Postoperative
coagulopathy was associated with poorer outcomes. Smaller FFP/RCC ratios and larger volumes of crystalloid infusion
were associated with development of coagulopathy and poorer prognosis of survival.
Trial registration: This study is retrospectively registered in UMIN Clinical Trials Registry (Registration 19 April
2016, registered number is R000025334 UMIN000021978).
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Background
Ruptured abdominal aortic aneurysm (rAAA) is a fatal
condition, with mortality rates of 38 to 50 % reported,
even in cases where surgery is performed [1–3]. Open
repair has generally been the standard operation; however,
recent reports have indicated that endovascular aortic
repair (EVAR) is equally effective [4]. In a randomized
controlled trial, EVAR was found to be not inferior to open
repair for treating rAAA [5].
Several studies have found associations between treat-
ment success in open repair of rAAA and factors includ-
ing advanced age, female sex [6], preoperative kidney
failure, chronic obstructive pulmonary disease history
[7], and deranged clotting [8]. But, few studies have in-
vestigated EVAR for rAAA, and we found limited data
examining correlations between perioperative coagulop-
athy and survival. Furthermore, no data are available
concerning preoperative treatment strategies, such as
fluid and blood transfusions.
Coagulopathy is thought to be closely linked with rAAA
survival [9]. Additionally, an association has been reported
between coagulopathy and incidence of abdominal com-
partment syndrome, a complication of EVAR for rAAA
[10]. Therefore, coagulopathy may also be an important
factor determining survival prognosis after EVAR.
Similar to rAAA, trauma–induced coagulopathy (TIC)
can be detrimental to a patient’s overall condition from
hemorrhagic shock and is known to worsen prognoses.
Moreover, it is known that high doses of crystalloids can
further worsen prognoses by contributing to TIC [11].
Early use of blood products is thought to improve prog-
noses [12]. Among patients undergoing EVAR for rAAA,
we expected to find a correlation between coagulopathy
incidence and postoperative survival prognosis, the vol-
ume and content of blood transfusions, and survival.
We retrospectively investigated associations between
preoperative and postoperative coagulopathy in patients
who underwent EVAR for rAAA at our hospital and 24-
h and 30-day postoperative survival. Additionally, we
examined how crystalloid infusion and blood transfusion
correlated with coagulopathy incidence. We also exam-
ined the relation of crystalloid infusion and blood trans-
fusion with 24-h and 30-day postoperative survival.
Methods
Patient selection
Subjects were all patients who underwent EVAR for rAAA
at our hospital during the period from October 2013 to
December 2015. Diagnosis of rAAA was made using
simple computed tomography (CT) or contrast-enhanced
CT. Observation of hematoma led to a diagnosis of rAAA.
Patients who underwent emergency surgery for symptom-
atic abdominal aortic aneurysms were excluded where
imaging did not show evidence of rupture.
This was a retrospective observational study. Prior to
use of treatment data, consent was obtained in all cases
from patients themselves or proxies with permission to
make decisions on behalf of patients. The study was
approved by a local ethical committee (approval No.
TGE 00576-025).
Data collection
Information was gathered from medical, nursing, medica-
tion, and emergency medical service records. The results of
blood tests performed when patients were admitted to the
emergency room were used as the preoperative values, and
results from tests performed when patients were admitted
to the ICU after surgery were used as the postoperative
values. Major coagulopathy was defined by an activated
partial thrombin time ratio (APTT) greater than 1.5, by a
prothrombin time and international normalized ratio (PT-
INR) greater than 1.5, or by a platelet count less than 50 ×
10/l. To investigate the content of blood products used, we
calculated RCC/FFP ratios and differences (RCC-FFP)
based on the volumes of blood products used during the
period from hospital arrival to ICU entry just after surgery.
Three treatment outcomes were observed: intraoperative
death, 24-h postoperative survival, or 30-day postoperative
survival.
Pre- and intraoperative management
Decisions to administer fluid and blood transfusions,
and about which compositions should be used, were
made by the physicians in charge of outpatient care from
hospital arrival to the start of surgery. In the period after
patients entered the operating room, during surgery, and
until the patients arrived in the ICU these decisions
were made by anesthesiologists.
In principle, surgeries commenced under local anesthesia
and general anesthesia was introduced after preparation
for use of an aortic occlusion balloon. General anesthesia
was administered before any incisions were made if the
anesthesiologist and surgeon agreed this could be done
safely.
Surgeries began without the use of heparin; however,
heparin was administered in cases where it was possible
to insert a balloon to occlude the aorta in order to
ensure that activated clotting time was at least 200 s.
Protamine was used to reverse the effects of heparin at
the end of the operation, administered at a dose equiva-
lent quantity. Following the end of the operation, all
patients were transferred to the ICU while sedated and
connected to an artificial respiratory device.
Statistical analysis
For continuous variables, means and standard deviations
were calculated. Categorical variables were presented as
n (percentage of total [%]). The Mann-Whitney test was
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used for analysis of continuous variables, whilst categor-
ical variables were compared using the chi-square test.
Differences were considered statistically significant at a
p-value of <0.05.
All statistical analyses were performed on a personal
computer using the statistical software package SPSS for
Mac (Version 22; SPSS Inc., Chicago, IL, USA).
Results
Treatment outcome
Forty-seven patients presenting with rAAA in our
hospital were enrolled in the study. One patient was
considered unfit for surgery. Of the 46 patients who
went to theater, 25 underwent EVAR and thus were
included in our analyses.
With regard to treatment outcomes, no patients died
in the operating theater, whilst three died due to abdom-
inal compartment syndrome (ACS) within 24-h postsur-
gery, and an additional two died between 24-h and
30 days postsurgery. One of these two patients died due
to respiratory failure and one of cancer.
Comparison of preoperative and postoperative
examination values
Data from the 25 subjects before and after surgery were
compared using paired t-tests. Statistically significant
changes were seen in APTTand PT-INR, which increased,
and platelet counts, which decreased. No patients pre-
sented with major coagulopathy prior to surgery, although
nine patients experienced major coagulopathy afterward
(Table 1).
Coagulopathy, fluid infusion, and blood transfusion
Patients who presented major coagulopathy after surgery
received larger total fluid transfusions from hospital ar-
rival to the end of surgery. More patients in the non-
survival groups for both 24-h and 30-day survival received
fluid transfusions of 1.5 L (Table 2).
The values for RCC/FFP ratio and RCC-FFP were
significantly larger in the group that exhibited major
coagulopathy than in the group that did not.
Coagulopathy and survival
Postoperative APTT was significantly longer in the 24-h
and 30-day non-survival groups in comparison with the
respective survival groups (Table 3).
A significantly greater number of patients in the 24-h
non-survival group exhibited major coagulopathy post-
operatively compared with the survival group. Similarly,
there more instances of major coagulopathy were ob-
served in the 30-day non-survival group than in the
survival group.
Fluid and blood transfusions and survival
Values for RCC/FFP ratios and RCC-FFP were signifi-
cantly larger in both the 24-h and 30-day non-survival
groups compared with the respective survival groups
Table 1 Comparison of the preoperative and postoperative
coagulation profiles in all participants
Preoperative Postoperative p
APTT (second) 27.8 +/- 5.2 47.3 +/- 30.1 0.002
PT-INR 1.2 +/- 0.2 1.4 +/- 0.2 <0.001
PLT counts (104/μL) 16.3 +/- 5.2 9.9 +/- 4.7 <0.001
Major coagulopathy (n) 0 9 <0.001
APTT activated partial thromboplastin time ratio, PT-INR prothrombin time and
international normalized ratio, PLT platelet




Preoperative APTT (second) 27.0 +/- 4.3 33.6 +/- 8.4 0.21
Postoperative APTT (second) 38.9 +/- 8.7 108.7 +/- 63.4 0.006
APTT change (second) 11.9 +/- 9.2 75.0 +/- 58.9 0.006
Preoperative PT-INR 1.2 +/- 0.16 1.2 +/- 0.2 0.802
Postoperative PT-INR 1.3 +/- 0.20 1.5 +/- 0.28 0.295
PT-INR change 0.16 +/- 0.17 0.33 +/- 0.33 0.503
Preoperative platelet counts
(104/μL)
16.1 +/- 5.4 17.3 +/- 3.0 0.616
Postoperative platelet counts
(104/μL)
10.2 +/- 5.0 7.7 +/- 1.9 0.558
Platelet count change (104/μL) 5.9 +/- 6.2 9.5 +/- 5.2 0.452
Preoperative major coagulopathy (n) 0 (0 %) 0 (0 %) NS




Preoperative APTT (second) 26.8 +/- 4.3 32 +/- 7.0 0.119
Postoperative APTT (second) 38.1 +/- 7.9 95.7 +/- 57.9 0.002
APTT change (second) 11.3 +/- 8.9 62.7 +/- 54.1 0.002
Preoperative PT-INR 1.2 +/- 0.16 1.23 +/- 0.19 0.0.767
Postoperative PT-INR 1.4 +/- 0.2 1.5 +/- 0.2 0.148
PT-INR change 0.16 +/- 0.18 0.30 +/- 0.28 0.436
Preoperative platelet counts
(104/μL)
16.2 +/-5.54 16.8 +/- 2.7 0.767
Postoperative platelet counts
(104/μL)
10.4 +/- 5.0 7.2 +/- 1.9 0.299
Platelet count change (104/μL) −5.7 +/-6.3 −9.6 +/- 4.0 0.335
Preoperative major coagulopathy (n) 0 (0 %) 0 (0 %) NS
Postoperative major coagulopathy (n) 5 (25 %) 4 (80 %) 0.01
APTT activated partial thromboplastin time ratio, PT-INR prothrombin time and
international normalized ratio, PLT platelet
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(Table 4). Patients with RCC/FFP ratios greater than 1.5
had higher risks of mortality.
Larger quantities of crystalloids were used in the both
the 24-h and 30-day non-survival groups compared with
the respective survival groups.
Discussion
For all subjects, values for postoperative APTT and PT-
INR were significantly longer than preoperative values.
While there were no instances of major coagulopathy pre-
operatively, the condition was observed in nine patients
postoperatively.
At both 24-h and 30 days postoperation, there were no
significant differences in preoperative APTT, PT-INR, or
major coagulopathy between the survival groups and non-
survival groups. These results concur with findings from a
previous study that examined factors related to survival
after open repair for rAAA and found no correlation be-
tween preoperative coagulopathy and mortality [13].
Conversely, our findings show that postoperative APTT
was significantly longer in the non-survival groups than in
the survival groups at both 24 h and 30 days. Furthermore,
APTT increased by a significantly larger proportion be-
tween pre- and postsurgery in the non-survival groups at
both 24 h and 30 days.
There were more instances of postoperative major
coagulopathy in the non-survival groups than in the sur-
vival groups at both 24 h and 30 days. In a previous
study of patients who underwent open repair for rAAA,
prolonged PT and prolonged APTT at postoperative ICU
entry were associated with poorer prognoses [14]. The
same appears to be true for patients treated with EVAR.
In the present study, a tendency for coagulopathy to
progress during the period from hospital arrival to the
end of surgery was observed among all cases, with pa-
tients who exhibited greater progression also exhibiting
higher mortality risks. Efforts to control the progression
of coagulopathy after hospital arrival could help to im-
prove survival prognoses.
ACS is a serious condition that can occur after EVAR
for rAAA and negatively affects survival [15]. Its mortal-
ity rate is nearly 100 % without treatment and is still
high (30–60 %) with appropriate treatment [16]. ACS is
thought to be caused by massive retroperitoneal hematoma
and diffuse visceral edema and is diagnosed when the ab-
dominal pressure exceeds 20 mmHg in combination with
endo-organ dysfunction. Early recognition and surgical
decompression of ACS is essential [17]. Coagulopathy is
reportedly a risk factor for ACS [12]. In fact, all the patients
who died within 24 h in the present study experienced
ACS and exhibited postoperative major coagulopathy. Rou-
tine measurement of intraabdominal pressure is useful for
detecting ACS. Especially in patients with coagulopathy
after EVAR for rAAA, intraabdominal pressure should be
monitored carefully. Additionally, we believe that main-
taining clotting function by FFP blood trans fusion and
limitation of crystalloid use can prevent ACS development.
In a report on trauma treatment by Veena et al. [18],
greater administered quantities of crystalloids were asso-
ciated with coagulopathy progression, cellular distension,
heart complications, and elevated abdominal compart-
ment pressure. In addition, incidence of ACS has been
linked to large fluid transfusions [19].




RCC (units) 5.63 +/- 5.3 13.6 +/- 7.0 0.004
FFP (units) 5.75 +/- 6.4 6.2 +/- 7.5 0.743
PC (units) 5.6 +/- 11.5 4.4 +/- 8.8 0.57
RCC/FFP ratio 1.1 +/- 0.23 2.00 +/- 0.73 0.015
RCC - FFP (units) 2.3 +/- 3.5 7.9 +/- 4.3 0.001
Preoperative crystalloid
volume (mL)
750 +/- 408 1589 +/- 1071 0.022
Total crystalloid volume (mL) 2214 +/- 893 3572 +/- 1391 0.014
Total crystalloids >1.5 L (n) 4 (25 %) 5 (56 %) 0.137
RCC red cell concentrate, FFP fresh frozen plasma, PC platelet concentrate
Table 4 Survival and blood and fluid transfusions
Survival Non-survival p
24-h survival
RCC (units) 7.3 +/- 5.3 17.7 +/- 7.8 0.035
FFP (units) 3.6 +/- 4.2 12.0 +/- 6.9 0.02
PC (units) 5.7 +/- 12.9 13.3 +/- 11.5 0.271
RCC/FFP ratio 1.3 +/- 0.6 1.6 +/- 0.8 0.014
RCC/FFP >1.5 L (n) 2 (9 %) 3 (100 %) 0.018
RCC - FFP (units) 4.5 +/- 4.7 5.7 +/- 5.7 0.006
Preoperative crystalloid
volume (mL)
877 +/- 615 2333 +/- 1041 0.01
Total crystalloid volume (mL) 2386 +/- 912 5083 +/-803 0.028
Total crystalloid >1.5 L (n) 5 (23 %) 3 (100 %) 0.037
30-day survival
RCC (units) 6.9 +/- 5.6 15.8 +/- 7.4 0.017
FFP (units) 3.4 +/- 4.2 10.0 +/- 6.9 0.116
PC (units) 5.7 +/- 12.9 10.0 +/- 11.5 0.96
RCC/FFP ratio 1.1 +/- 0.6 1.8 +/- 0.8 0.001
RCC/FFP > 1.5 L (n) 1 (5 %) 4 (70 %) 0.03
RCC - FFP (units) 3.5+/-4.7 5.8+/-4.6 0.03
Preoperative crystalloid
volume (mL)
847 +/- 615 2125 +/- 946 0.003
Total crystalloid volume (mL) 2341 +/- 9.6 4550 +/- 1252 0.012
Crystalloids >1.5 L (n) 5 (25 %) 4 (80 %) 0.01
RCC red cell concentrate, FFP fresh frozen plasma, PC platelet concentrate
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In the present study, quantities of crystalloids adminis-
tered were significantly higher among patients with major
coagulopathy. Furthermore, quantities of crystalloids used
were significantly higher in the non-survival groups at
both 24-h and 30 days. Crystalloid transfusion is associ-
ated with coagulopathy onset in rAAA patients who
undergo EVAR and is thought to have a negative effect on
prognosis. In a study of trauma patients, cases that re-
ceived large quantities of crystalloids in initial transfusions
reportedly required larger blood transfusions [20]. It is
possible that limiting use of crystalloids can prevent post-
operative coagulopathy and can make better the prognosis
of survival.
In the present study, values for both RCC/FFP ratio and
RCC-FFP were larger among patients with postoperative
major coagulopathy. Previously, a prospective study of pa-
tients who underwent open surgery for rAAA found that
aggressive FFP and PLT administration significantly inhib-
ited the prolongation of postoperative APTT [21].
In this study, the relatively lesser use of FFP com-
pared with RCC appears to be associated with major
coagulopathy.
Studies investigating blood transfusion composition
and survival prognosis in trauma patients have indicated
that an appropriate target for RCC/FFP ratios is between
3 and 4 [22]. However, a study conducted by the military
found that maintaining an RCC/FFP ratio close to 1 led
to increased survival rates [23]. A retrospective investi-
gation of RCC/FFP ratios in trauma patients reported a
link between a 1:1 RCC/FFP ratio and positive prognoses
[24]. Furthermore, the PROPPR randomized clinical
trial, which divided trauma patients into an RCC:FFP:PC
= 1:1:1 group and an RCC:FFP:PC = 2:1:1 group, found
that the former group achieved hemostasis and experi-
enced less exsanguination in 24 h, although no signifi-
cant differences in mortality between the two groups
were observed [25]. Most of the above results suggest
that quantities of FFP equal to those of RCC can be use-
ful for improving the survival prognoses of patients with
rAAA receiving EVAR by maintaining a coagulation pro-
file and achieving hemostasis.
Our hospital does not have a protocol for blood transfu-
sion in rAAA patients. The physician in charge determines
the content of transfusions based on test results. Mean
transfusion quantities were RCC 10.0 +/- 5.70 units and
FFP 4.4 +/- 3.3 units, representing a RCC/FFP ratio greater
than 1. On the basis of results from the present and previ-
ous studies, it appears that basing decisions for how much
FFP to administer on test results may not keep up with the
patient’s progression. For rAAA patients undergoing EVAR
who require blood transfusions, coagulopathy may be con-
trolled and survival prognosis improved by following a
transfusion protocol that uses a 1:1 RCC/FFP ratio and
administers FFP early.
Conclusion
Coagulopathy progressed during care in the emergency
outpatient clinic and the operations, and postoperative
coagulopathy was associated with poorer outcomes. We
suggest that smaller FFP/RCC ratios and larger volumes of
crystalloid infusions potentially contributed to coagulopa-
thy and ACS development, and poor survival prognosis.
Limitations of this study include the small sample
number and its retrospective design, and further inves-
tigation is needed.
Abbreviations
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